Related Experiment Video
Updated: May 5, 2026

08:04
Murine Fetal Echocardiography
Published on: February 15, 2013
17.2K
Fetal loss associated with excess thyroid hormone exposure
João Anselmo1, Dingcai Cao, Theodore Karrison
1Endocrinology Unit, Hospital Divino Espírito Santo, Ponta Delgada, Azores-Portugal.
JAMA
|August 12, 2004
Summary
Mothers with resistance to thyroid hormone (RTH) experienced higher miscarriage rates. Their unaffected infants showed lower birth weights and suppressed TSH, indicating fetal thyrotoxicosis from excess maternal thyroid hormone (TH).
Area of Science:
- Endocrinology
- Reproductive Medicine
- Genetics
Background:
- Maternal thyroid disorders significantly impact pregnancy outcomes.
- Studying fetal thyrotoxicosis is challenging as direct fetal hormone assessment is limited.
- Resistance to thyroid hormone (RTH) offers a model to study TH excess effects on the fetus.
Purpose of the Study:
- To investigate the impact of excessive thyroid hormone (TH) exposure on fetuses carried by mothers with RTH.
- To assess pregnancy outcomes in mothers with RTH who are otherwise euthyroid.
- To determine if high maternal TH levels lead to fetal thyrotoxicosis.
Main Methods:
- Retrospective analysis of 167 individuals from an Azorean family with RTH.
- Genotyping confirmed the Arg243-->Gln mutation in the TH receptor beta gene in affected individuals.
- Comparison of pregnancy outcomes, birth weights, and neonatal TSH levels between affected mothers, affected fathers, and unaffected relatives.
Main Results:
- Affected mothers exhibited a significantly higher miscarriage rate (22.9%) compared to controls (2.0%-4.4%).
- Unaffected infants born to affected mothers had lower birth weights (mean SD score -1.79) and undetectable TSH levels.
- Affected mothers had a trend towards more affected offspring (20 affected vs. 11 unaffected).
Conclusions:
- High miscarriage rates in mothers with RTH may disproportionately affect unaffected fetuses.
- Excess maternal TH levels in RTH cause fetal thyrotoxicosis, evidenced by low birth weight and suppressed TSH in unaffected infants.
- These findings suggest a direct toxic effect of thyroid hormone excess on fetal development.
Related Concept Videos
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Hypothyroidism II: Pathophysiology
26
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26

